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Cytokine receptors from the IL-6 receptor family are
comprised of ligand specific a chains and a common
signalling chain, gp-130, which is also required for
high affinity binding. A cDNA library generated
from the -TC3 SV40 T-antigen transformed insuli-
noma cell line was screened for members of this
receptor family potentially relevant to both beta cell
development and autoimmunity. Degenerate oligo-
nucleotide primers to a consensus region of these
receptors were used and the IL-11 receptor c chain
was identified. Despite confirmation of IL-11 recep-
tor mRNA expression, iodinated bioactive IL-11 did
not bind specifically to -TC3 cells and gp-130-
dependent cytokines did not elicit signalling events
in beta cell lines. This was explained by absence of
gp-130 protein or mRNA in the beta cell lines tested
and in primary islets. We conclude from these re-
sults that the previously recognised effects of IL-
6 family member cytokines on pancreatic islets must
be indirect via other non-beta cells within the is-
let, rather than due to direct effects on beta cells
themselves.
Keywords: Beta cell; Cytokine receptors; Insulinoma cell lines;
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INTRODUCTION
The IL-6 receptor is a member of a cytokine
receptor family which includes IL-11, LIF,
oncostatin M (OSM), ciliary neurotrophic factor
(CNTF) and cardiotrophin-1 receptors. These
receptors utilize a common receptor chain, gp-
130, for signal transduction. Although the
primary effects of IL-6 and LIF have been
described on cells within the haematopoeitic
lineage
[1] they also act to promote gene
expression, growth and differentiation of non-
haematopoietic cells [2-4] (reviewed in Nicola,
1998). Whether or not cytokines of this family
have an effect on pancreatic beta cell develop-
ment is unknown, however regenerative effects
on endocrine cells have been described in IL-6
transgenic mice. 51 Other members of the IL-6
receptor family have also been shown to affect
development of a variety of cell types. IL-11, for
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example, is known to stimulate haematopoiesis,
B lymphocyte function, I6, 7] small intestinal
cell recovery following cytoablative therapy I8
and neuronal differentiation of hippocampal
progenitor cells. 91 Another IL-6 family member,
CNTF, has been shown to support the survival
of parasympathetic neurones from the chick
ciliary ganglion, I1 while enhancing the survi-
val of sensory neurones, Illl motor neurones
[12]
[131 and hippocampal neurones.
Type 1 (insulin-dependent) diabetes is a T cell
mediated autoimmune disease in which the
pancreatic beta cells are selectively destroyed.
A role for the IL-6 family of cytokines in auto-
immune diabetes has been postulated. IL-6
is produced within islets, possibly by endocrine
as well as inflammatory cells, and administra-
tion of neutralizing antibody to IL-6 decreased
progression of diabetes in the non-obese diabetic
(NOD) mouse.
[14] IL-6 was shown to have
direct effects on insulin secretion by rat islets
in vitro,
[15"16] and to enhance the inhibitory
effects of IL-1 on rat islets. Recently, CNTF was
also shown to enhance the destructive effects of
IL-1 on rat islets by enhancing IL-l-mediated
nitric oxide production by beta cells. 171 CNTF
mRNA was also detected in rat islet cells.
Using a degenerate oligonucleotide screening
strategy to identify known or novel members of
the IL-6 cytokine receptor family involved in beta
cell function, we have found expression of the
IL-11 receptor on a beta cell line. However, when
the functional effects of the IL-11 receptor and
other members of this family were examined on
beta cell lines, we were unable to detect an effect.
We demonstrate that this is due to absence of
the signalling component of the receptor, gp-130,
on both beta cell lines and primary murine islets.
MATERIALS AND METHODS
Cell Culture and Cytokines
Mouse insulinoma (fl-TC3, NIT) cells were
continuous clonal cell lines obtained from the
American Type Tissue Culture (ATCC, Rock-
ville, MD) derived from transgenic mice ex-
pressing the SV-40 large T-antigen under the
control of the rat insulin promoter. I18’191 fl-
TC3 cells were derived from transgenic
C57BL/6JxDBA/2J mice whereas NIT cells were
derived from transgenic non-obese diabetic
(NOD) mice. MUR21 and M127 myeloid leukae-
mia cells were the gift of Dr. Doug Hilton
(Walter and Eliza Hall Institute, Melbourne,
Australia). These cells were maintained at 37C
in 10% CO2 in Dulbecco’s minimal essential
medium (DMEM) supplemented with 10%
foetal bovine serum (FBS), glucose (16.5 mM),
non-essential amino acids and antibiotics.
NIH 3T3 cells were maintained at 37C in 10%
CO2 in DMEM with 5% FBS and antibiotics.
Pancreatic islets isolated from both NOD and
C57BL/6xSJL mice were purified and main-
tained in short term culture as described.2
Mouse embryos were dissected, the pancreata
removed and total RNA isolated using
RNAzol (Tel-Test Inc., Friendswood, TX) ac-
cording to the manufacturer’s instructions.
Murine IL-3 and IL-11 were used as culture
supernatants from WEHI 3BD-. Recombinant
murine IL-6 and LIF were from Dr. Richard
Simpson (Ludwig Institute, Melbourne, Aus-
tralia) and used at 10ng/ml and 500U/ml
respectively. Insulin was measured by radio-
immunoassay (Phadeseph, Pharmacia, Uppsala,
Sweden).
Antibodies
Anti-gp-130 antibody (M-20, Santa Cruz Biotech-
nology, Santa Cruz, CA) was an affinity-purified
rabbit polyclonal antibody raised against amino
acids 895- 914 corresponding to the carboxy-ter-
minus of murine gp-130. Monoclonal anti-ISGF3
91/84 (Transduction Laboratories, Lexington,
KY) and polyclonal anti-STAT3 (Santa Cruz Bio-
technology, Santa Cruz, CA) were used to
identify complexes in electrophoretic mobility
shift assays (EMSAs). Control antibodies wereCYTOKINE RECEPTORS IN BETA CELLS 241
derived from pre-immune rabbits or mice as
required.
secondary screen. This procedure was re-
peated a third time to obtain pure plaques.
Library Screening
Approximately 1 x 106 plaques from a fl-TC3 A-
ZAP cDNA library were screened by colony lift
procedures as described. I211 Briefly, infected
bacteria (XL1-Blue) were grown on 150mm
plates and plaques transferred to duplicate
150mm membranes (Colony/Plaque Screen,
NEN Research products, Boston, MA). Dena-
tured, fixed, bacterial filters were rinsed with
2XSSC (150mM sodium chloride, 15mM sodium
citrate dihydrate), prior to pre-hybridisation
overnight in hybridisation buffer (6X SSC,
2mg/ml BSA, 2mg/ml Ficoll, 100tM ATP,
10 tg/ml tRNA, 2mg/ml polyvinylpyrrolidone,
2mg/ml salmon sperm DNA, 200tg/ml so-
dium azide and 0.1%(w/v) SDS) at 42C.
Degenerate oligonucleotide primers [300ng-
WSAWS; 5’-TGGAG(T/C)GC(A/C/G/T)-
TGGAG(T/C)-3’, WSEWS; 5’-TGGAG(T/C)
GA(A/G)TGGAG(T/C)-3’, WSDWS; 5’-TGGAG-
(T/C)GA(C/T)TGGAG(T/C)] were phosphory-
lated by end labelling with T4 polynucleotide
kinase using 160tCi [.y_32p] ATP (Promega,
Madison, Wi, USA). A pre-packed gel filtration
column (NAP-5, Pharmacia, Uppsala, Sweden)
was employed to separate unincorporated ATP
from labelled probes and filters were hybridised
overnight at 42C in hybridisation buffer. Filters
were rinsed twice at room temperature in
6XSSC, 0.1% SDS, washed twice in 6XSSC, 0.1%
SDS at 48C and rinsed twice with 2XSSC at
room temperature, prior to drying by brief blot-
ting then mounting for autoradiography at
-70C using Kodak X-Omat-AR film and inten-
sifying screens, for 7 days. Positive plaques on
duplicate filters were selected, eluted in l ml
100mM NaC1, 10mM MgC12, 10mM Tris-HC1,
pH 7.4 with 0.5% (w/v) gelatin and 0.5% (v/v)
chloroform and stored at 4C. XL1-Blue cells
were subsequently infected with the eluate
from the primary plugs and replated for a
Identification of Plaques
Positive plaques were screened for inserts by
PCR using primer combinations generated to 5/-
and 3 flanking regions of pBK-CMV phagemid
vector (Stratagene Cloning Systems, La Jolla,
CA) as follows:
51-GATTACGCCAAGCTCGAAATTAACC-3
(HNl-forward primer)
51-TACGACTCACTATAGGGCGAATTGG-3
(HN2-reverse primer)
PCR conditions were 94C/3’+35cycles
(94C/1 I, 50C/1 I, 72C/3’)+72C/5I+4C in
20 tl final volume. The products were resolved
on 1.5% agarose gels. Clones containing insert
were prepared for sequencing by dideoxy ter-
minator sequencing using a 320A sequenator
(Applied Biosystems, Foster City, CA). The
BLAST algorithm 22 was used to search data-
bases for protein and DNA homologies.
Northern Analyses
Total or poly (A) +-selected RNA transcripts
(purified using PolyATract mRNA isolation
system III, Promega, Madison, WI) were exam-
ined by Northern analyses as described. I231
Briefly, RNA was electrophoresed on a 1%
(v/v) formaldehyde agarose gel and transferred
to Genescreen Plus (Dupont, NEN) nitro-
cellulose membrane in 10X SSC. Blots were
pre-hybridised in ExpressHyb (Clontech Labora-
tories, Palo Alto, CA), for 30 min at 68C. cDNA
probes were labelled with oz-[32p] dATP (Dupont,
NEN, 3000Ci/mmol) by random priming to a
specific activity of I x 108 cpm/tg, added to filt-
ers in prehybridisation solution, and incubated
for I h at 68C. The membrane was washed at RT
in 2x SSC containing 0.05% (w/v) SDS for I h, at
65C in lx SSC containing 0.1% (w/v) SDS for
lh, and exposed to autoradiography at -70C.242 G. NASELLI et al.
Immunoblotting
Cells were lysed in lysis buffer A (10mM
CHAPS, 50mM Hepes, pH 7.6, 150mM NaC1,
3mM phenylmethylsulphonyl fluoride (PMSF),
20 tg/ml leupeptin, 20 tg/ml aprotinin (Sigma,
St Louis, MO)) and protein concentration was
estimated using commercially prepared reagent
(Bio-Rad, Hercules, CA). Proteins from cell
lysates (20tg/lane) were resolved by SDS-
PAGE, electroblotted onto nitrocellulose mem-
branes (Schleicher and Schuell Germany), and
blocked for 16 h in 5% skim milk in phosphate
buffered saline (PBS).
Membranes were incubated with primary
antibody at 0.5g/ml (final) for 2h at 25C,
followed by four washes in PBS and incubation
with anti-rabbit horseradish peroxidase-labelled
secondary antibody (Silenus, Australia) diluted
1:1000 for lh at 25C. Following five washes
in PBS, blots were developed with ECL reagent
(Amersham International, Amersham, UK) and
bands detected by autoradiography.
Binding Studies with IL-11
Binding studies were performed essentially as
described by Hilton and Nicola.
[24] Briefly, 106
cells in 40 tl RPMI-1640 or DME medium con-
taining 20mM Hepes, pH7.4 and 10% (v/v) FCS
were incubated overnight on ice with 1 x 105
cpm 125I-labelled IL-11 with or without a 100-
fold excess of unlabelled IL-11. Cell associated
and free 125I-labelled IL-11 were separated by
rapid centrifugation through 180tl FCS and
quantitated in a -y-counter.
Electrophoretic Mobility Shift
Assay (EMSA)
Nuclear extracts were prepared as described. 251
Briefly, cells were lysed in lysis buffer B (10mM
Hepes pH 7.9, 10mM KC1, 1.5mM MgC12,
0.5mM PMSF, 10 g/ml leupeptin, 0.5mM
DTT). The lysate was vortexed with 25tl
10% NP40 and centrifuged. The pellet was
resuspended in 420mM NaC1, 20mM Hepes
pH 7.9, 1.5mM MgC12, 0.2mM EDTA, 10%
glycerol, 0.5mM PMSF, 10tg/ml leupeptin
and 0.5mM DTT and centrifuged at 12,000rpm
at 4C for 5 min. EMSAs were carried out using
oligonucleotides labelled with o-[32p] dATP by
end-labelling as described previously. The se-
quence of the c-sis-inducible element probe
(M67) used was 5’-GATCTAGGGATTTCCGG-
GAAATGAAGCT-3t. I261 EMSAs containing 2 tl
of nuclear extract were incubated on ice in
reaction buffer (13.3mM Hepes pH 7.6, 0.7mM
EDTA. 3.3mM MgC12, 34mM KC1, ImM DTT,
10% glycerol and 0.5 tg poly (dI-dC)). Reactions
proceeded for 15 min followed by the addition
of 32p-labelled oligonucleotide ( 15,000 dpm).
Competitor cDNA was added at 100x molar
excess.
When antibodies specific for transcription
factors were employed in EMSAs, antibody was
reacted with extracts for I h on ice prior to
the addition of labelled oligonucleotide. After
15min, the DNA-protein complexes were ana-
lysed by electrophoresis through a 5% non-
denaturing polyacrylamide gel in 0.25x TBE
(TBE is 50mM Tris, 50mM boric acid and
lmM EDTA). Gels were subsequently dried
and exposed to x-ray films at -70C.
RESULTS
Identification of Cytokine Receptors
We screened a pancreatic beta cell line, fl-TC3,
to examine cytokine receptors which may be
important during endocrine cell development.
Degenerate oligonucleotides corresponding to
the cytokine receptor homology domain: Trp-
Ser-Ala-Trp-Ser (WSAWS) were employed as a
probe to screen 106 plaques from a fl-TC3
&-ZAP cDNA library. We identified two in-
dependent cDNAs encoding the murine IL-11
receptor alpha chain. The sequences obtained
corresponded to nt19-170 of the full-length,
murine IL-11 receptor alpha chain. This
was of immediate interest to us because ofCYTOKINE RECEPTORS IN BETA CELLS 243
previous data implicating cytokines related to
IL-11 in the pathogenesis of diabetes.
Lack of IL-11 Binding to, and Effects on,
//-TC3 Cells
To determine whether IL-11 could directly bind
to the high affinity IL-11 receptor, 125I-labelled
IL-11 was reacted with fl-TC3 cells or the IL-11
receptor/gp-130 deficient myeloid leukaemia
cell line MUR21, or M1 cells (which express
gp-130) stably transfected with IL-11 receptor
(M127). Radioiodinated IL-11 bound specifically
to the high affinity receptor-containing M127
cells but not to the receptor-deficient MUR21
cells or to fl-TC3 cells (Fig. 1).
IL-11 and other members of this family of cyto-
kines signal via activation of the transcription
3000
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FIGURE Radioligand binding. Specific binding of radio-
iodinated IL-11 to fl-TC3 cells, IL-11 receptor positive M127
cells and IL-11 receptor deficient MUR21 cells. Results are
the mean + 2 S.D. of two experiments each performed in
triplicate.
factors STAT1 and STAT3. Phosphorylated
STATS 1 and 3 homo- and hetero-dimerize
and are then able to bind to a modified serum
treatment:
A ITC-3 B NIT C M127
z u. "T, z 9 u. ’7 z
NIT cells + m67 NIH 3T3 cells + m67
Treatment: nil IFN-y IL-6 nil IFN-y IL
FIGURE 2 Signalling through gp-130. Electrophoretic mobility shift assays (EMSAs) showing binding to oligonucleotide M67 of
nuclear proteins in extracts from fl-TC3 (A), and NIT (B) cells after treatment with IFN-3,, IL-6, LIF, IL-11. M127 cells were
treated with IFN-3, or 1L-11 (C). Shifted complexes representing STAT1 and STAT1/3 are indicated. D, EMSA of NIT cells (a)
and NIH 3T3 cells (b) after 30min treatment with IFN--y or IL-6. Extracts were pre-incubated with antiserum (Ab) to STAT1,
STAT3 or pre-immune rabbit serum (NRS). Complexes containing either STAT1, STAT3 or both are "super-shifted" or
decreased in intensity following incubation with specific antibodies. IL-6 treated NIT extracts were not incubated with anti-sera
because no IL-6 induced complex was observed.244 G. NASELLI et al.
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FIGURE 3 Expression of IL-11 and gp-130 receptors. Expression of gp-130 protein on beta cells. (A) Western blot of cell lysates
from fl-TC3, NIT, or gp-130 containing haematopoietic cells, probed with anti-gp-130 polyclonal antibody. (B) Autoradiograph
ofmRNA from fl-TC3 cells and M127 cells probed with radiolabelled cDNA for gp-130 (A), IL-11 receptor c-chain (B) or mouse
fl-actin (). (C) RT-PCR analyses of IL-11 receptor and gp-130 expression. RT-PCR of mRNA from M127 and fl-TC3 cells (A),
embryonic mouse pancreas (B) or isolated mouse islets (), amplified with primers coding for cDNAs from murine IL-11
receptor c-chain or murine gp-130. Reactions performed in the absence of DNA template are designated c.
responsive element termed M67. While fl-TC3
cells were capable of responding to IFN--y with
an appropriate STAT1 product in an electro-
phoretic mobility shift assay (EMSA), we could
not detect STAT1/3 heterodimer or STAT3
homodimers in response to IL-11, IL-6 or LIF
(Fig. 2A). To confirm that these observations
were not restricted to fl-TC3 cells we examinedCYTOKINE RECEPTORS IN BETA CELLS 245
NIT cells derived from SV-40 T-antigen trans-
genic non-obese diabetic (NOD) mice. While
NIT cells treated with IFN--y produced a STAT1
band shift, IL-11, IL-6 and LIF did not (Fig. 2B).
In contrast, M1 myeloid leukaemia cells stably
transfected with the IL-11 receptor (M127 cells)
had bands consistent with STAT1 and STAT1/3
complexes after cytokine treatment (Fig. 2C).
Anti-STAT1 and anti-STAT3 antibodies were
used to identify STAT complexes in supershifts
of lysates of NIT cells or NIH 3T3 cells after
treatment with IFN--y or IL-6. Although both
NIT and NIH 3T3 cells contained phosphory-
lated STAT1 homodimers that could be detected
by supershift with anti-STAT1 antibodies after
IFN--y treatment, only NIH 3T3 cells could
respond to IL-6 treatment with subsequent
phosphorylation of STAT3 and supershift by
anti-STAT3 antibodies (Fig. 2D). Consistent with
lack of cytokine receptor activation, no effects of
IL-11, IL-6 or LIF were observed on insulin
secretion or growth rates of fl-TC3 cells (data not
shown). It was not clear that these assays could
rule out actions of these cytokines that may be
relevant to the pathogenesis of autoimmune
diabetes (e.g., stimulation of chemokine expres-
sion, increased susceptibility to other inflam-
matory effector molecules etc.). Because of our
interest in evidence linking these cytokines to
diabetes we decided to look further into why no
effects were detected.
Failure to Detect gp-130 Expression
in Beta Cells
To determine whether the failure of beta cells to
respond to cytokines was caused by a deficiency
in the adapter and signalling molecule gp-130,
protein and mRNA expression was examined.
Extracts from the beta cell lines (fl-TC3 and NIT)
and from positive (M127) and negative (MUR21)
control cell lines were immunoblotted with gp-
130 specific antibodies. A band of appropriate
size was detected with anti-gp-130 antibodies in
detergent extracts from M127 cells but not in
extracts from fl-TC3, NIT or receptor deficient
MUR21 cells (Fig. 3A). IL-11 c chain mRNA was
expressed in both M127 cells and fl-TC3 cells but
no transcript for gp-130 was detected in mRNA
from fl-TC3 cells as shown by Northern blot
(Fig. 3B) or RT-PCR (Fig. 3C). Similarly no gp-
130 transcript was found in primary islets by RT-
PCR and no gp-130 protein was detected in islets
by immunoblotting (not shown). Gp-130 cDNA
was not detected in the developing pancreas at
any stage of development examined (Fig. 3C).
We have been unable to find gp-130 in the RNA
samples tested which have come from a limited
range of insulinoma cell lines and islets isolated
from more than one mouse strain, indicating
that mouse beta cells in general are unlikely to
be able to respond via gp-130.
DISCUSSION
The role of cytokines in endocrine cell function is
unclear, however several reports have suggested
the potential involvement of the IL-6 family of
cytokines in fl-cell development. Indeed IL-6
and CNTF have been shown to be secreted by
mature pancreatic fl-cells, raising the possibility
that locally produced cytokines could provide
important paracrine or autocrine signals to
endocrine tissue.
[27-29] We have employed a
cDNA library screening strategy, using oligonu-
cleotides to the conserved WSA/D/EWS motif
of the cytokine receptor family to identify
cytokine receptors that may have a role in endo-
crine cell function.
We identified mRNA for the c-chain of the IL-
l1 receptor. The IL-11 receptor c-chain could be
detected in both transformed mouse cell lines
and freshly isolated mouse islets (data not
shown). These observations would suggest a
potential role for this recently described member
of the IL-6 cytokine receptor family in fl-cells.
However, we consistently failed to observe a
response to IL-11 by fl-cell lines in culture. In
addition we could not detect specific binding of246 G. NASELLI et al.
radioiodinated IL-11 to fl-cells when compared
to a control haematopoietic cell line. These
observations suggested that a component of
the receptor complex might not be functional.
The overlapping biological and biochemical
activities of the IL-6 family of cytokines have
been attributed to the sharing of an affinity-
converting signal-transducing molecule, gp-130
by distinct cytokine receptor subunits. I31 The
mature gp-130 molecule is a transmembrane
glycoprotein that incorporates the conserved
cytokine receptor homology domain (four n-
terminal cysteines and a c-terminal WSXWS
motif) on the second and third extracellular
fibronectin-like repeats. Ligand binding results
in gp-130 phosphorylation on tyrosine and the
subsequent transmission of an intracellular sig-
nal. The IL-11 receptor is critically dependent on
gp-130 for both high affinity ligand binding and
subsequent signal transduction.
[21] We could not
detect murine gp-130 mRNA or protein in fl-cell
lines, despite being able to detect gp-130 in
control cells. These observations were supported
by the failure of IL-11, IL-6 and LIF to induce
phosphorylation of STAT signalling molecules in
cultured fl-cells, a pathway dependent on gp-
130. [31’321 In contrast, these cells could readily
respond through STATs to IFN-% These data
show that transformed fl-cells are deficient in
gp-130. The observation that whole islets did not
contain detectable levels of gp-130 suggests
that c and &cells, which together with fl-cells
comprise the majority of the cells in the islet, may
also be deficient in gp-130. Indeed RT-PCR
analyses of transformed murine c-cells failed to
show transcripts for gp-130 (data not shown).
While we are reporting an essentially negative
study, the results are important in interpret-
ing the literature on the interactions between
this family of cytokines and pancreatic beta
cells. Deficiency of gp-130 on both mature and
developing endocrine cells suggests that this
family of cytokines has no role in endocrine
cell development. However, it is possible that
cytokine mediated developmental effects could
occur between E9 and E14 when the pancreatic
primordia first appears. The IL-6 family of
cytokines has been implicated in the patho-
genesis of autoimmune diabetes. IL-6 has been
reported to affect glucose mediated insulin
release [33] and islet insulin content and oxida-
tion [34], although these effects were dependent
on co-incubation with IL-1. A recent report has
stated that CNTF and IL-6 are able to potentiate
the IL-l-induced inhibition of insulin secretion
by rat islets. Our data suggests that this can only
be due to indirect effects of these cytokines on
other cells within the islet such as resident
leukocytes. I171 These cells might then release
other factors capable of directly interacting with
beta cells such as IL-1. In a transgenic mod-
el, expression of IL-6 under the control of the
insulin promoter was reported to result in a
complex, localised inflammatory reaction with
islet hyperplasia. 51 In contrast, it has been re-
ported that IL-6 does not affect transformed
rat fl-cell proliferation or hormone secretion and
is not synergistic with IFN--y or TNF-fl.
35 IL-6
has also been reported not to affect cAMP levels
in foetal rat pancreatic islets.
[36]
Although a link between the ability of fl-cells
to produce IL-6 and fl-cell destruction has been
suggested, no convincing evidence directly
demonstrates a specific response to IL-6 family
cytokines by fl-cells. Our own studies on the
effects of cytokines on the regulation of gluta-
mate decarboxylase synthesis by isolated rat
islets have shown that while IL-lfl and IFN--y
had significant inhibitory effects, IL-6 and LIF
had no effect. 37 In light of the current data
showing the absence of gp-130 expression it is
not surprising that no effect was seen.
In conclusion, we have demonstrated the pre-
sence of c-chains for the IL-11 receptor on
cultured fl-cells and isolated rodent islets. This
cytokine receptor, however, is functionally in-
active because the signal transducing co-recep-
tor molecule gp-130 is not expressed on these
tissues. In addition, both LIF and IL-6 failed to
induce either biological or signalling events onCYTOKINE RECEPTORS IN BETA CELLS 247
cultured fl-cells. These observations have im-
plications for the interpretation of studies using
these cytokines to understand the destructive
or inflammatory mechanisms involved in the
pathogenesis of diabetes. There is a long list of
potential effector mechanisms of beta cell de-
struction in autoimmune diabetes. These include
membrane bound and soluble products of T cells
and macrophages. Our strategy is to directly test
each of these in turn. The fact that gp-130 is not
expressed on mouse beta cells eliminates this
family of cytokines as direct mediators of beta
cell destruction but does not rule out possible
indirect effects.
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